Clinical and Histologic Findings in ACTA1-Related Nemaline Myopathy: Case Series and Review of the Literature
Carregando...
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
DONKERVOORT, Sandra
HU, Ying
OLIVEIRA, Acary Sousa Bulle
BONNEMANN, Carsten
Citação
PEDIATRIC NEUROLOGY, v.75, p.11-16, 2017
Resumo
BACKGROUND: Nemaline myopathy is a rare congenital disease of skeletal muscle characterized by muscle weakness and hypotonia, as well as the diagnostic presence of nemaline rods in skeletal muscle fibers. Nemaline myopathy is genetically and phenotypically heterogeneous and, so far, mutations in 11 different genes have been associated with this disease. Dominant mutations in ACTA1 are the second most frequent genetic cause of nemaline myopathy and can lead to a variety of clinical and histologic phenotypes. PATIENTS AND METHODS: We present a series of ACTA1-related cases from a Brazilian cohort of 23 patients with nemaline myopathy, diagnosed after Sanger sequencing the entire coding region of ACTA1, and review the literature on ACTA1-related nemaline myopathy. RESULTS: The study confirmed ACTAI mutations in four patients, including one with intranuclear rods, one with large intracytoplasmic aggregates, and two with nemaline intracytoplasmic rods. A repeat muscle biopsy in one patient did not show histological progression. CONCLUSION: Despite the recognized phenotypic variability in ACTA1-related nemaline myopathy, clinical and histological presentations appear to correlate with the position of the mutation, which confirms emerging genotype/phenotype correlations and better predict the prognosis of affected patients.
Palavras-chave
Nemaline myopathy, ACTA1, congenital myopathy, muscle biopsy
Referências
- Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157
- Castiglioni C, 2014, MUSCLE NERVE, V50, P1011, DOI 10.1002/mus.24353
- Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005
- Goebel HH, 2006, J CHILD NEUROL, V21, P545, DOI 10.2310/7010.2006.00089
- Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P13, DOI 10.1016/S0960-8966(96)00404-X
- Goebel HH, 2004, J CHILD NEUROL, V19, P149
- HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0
- Hung RM, 2010, NEUROMUSCULAR DISORD, V20, P238, DOI 10.1016/j.nmd.2010.01.011
- JENIS EH, 1969, ARCH NEUROL-CHICAGO, V20, P281
- Kaimaktchiev V, 2006, MUSCLE NERVE, V34, P369, DOI 10.1002/mus.20521
- Kaindl AM, 2004, J MED GENET, V41, P842, DOI 10.1136/jmg.2004.020271
- Laing NG, 2004, ANN NEUROL, V56, P689, DOI 10.1002/ana.20260
- Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059
- Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370
- Malfatti E, 2016, REV NEUROL-FRANCE, V172, P614, DOI 10.1016/j.neurol.2016.08.004
- North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705
- Nowak D, 1999, Postepy Biochem, V45, P261
- Nowak KJ, 2013, ACTA NEUROPATHOL, V125, P19, DOI 10.1007/s00401-012-1019-z
- Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004
- Romero NB, 2013, CURR OPIN NEUROL, V26, P519, DOI 10.1097/WCO.0b013e328364d681
- Rubenstein PA, 2014, CYTOSKELETON, V71, P211, DOI 10.1002/cm.21169
- Selcen D, 2015, NEUROMUSCULAR DISORD, V25, P488, DOI 10.1016/j.nmd.2015.04.002
- Sewry CA, 2015, NEUROMUSCULAR DISORD, V25, P388, DOI 10.1016/j.nmd.2015.02.003
- Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9
- Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006
- Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004
- WALLGRENPETTERSSON C, 1988, J NEUROL SCI, V83, P243, DOI 10.1016/0022-510X(88)90072-X
- Witting N, 2016, MUSCLE NERVE, V53, P388, DOI 10.1002/mus.24765
- Yuen M, 2015, J CLIN INVEST, V125, P456, DOI 10.1172/JCI80057
- Zukosky K, 2015, JAMA NEUROL, V72, P689, DOI 10.1001/jamaneurol.2015.37